52328-48-0 Usage
General Description
4-tert-Butyl-2-methoxybenzoic acid, also known as methyl amyl-4 is a chemical compound that belongs to the class of organic compounds known as Benzoic acids. These are characterized by an acid moiety of a benzene ring bearing a carboxylic acid substitution. This chemical compound, precise with molecular formula C12H16O3, has a molecular weight of 208.25 g/mol. Its exact mass is 208.113 g/mol, and it has a heavy atom count of 15. While its applications may vary, it needs to be handled with caution due to the properties it exhibits. As with any chemical, the handling, safety, and disposal of 4-tert-Butyl-2-methoxybenzoic acid should follow rigorous industry standards, and the specific instructions of the material safety data sheet, to ensure its usage doesn't harm the environment or human health.
Check Digit Verification of cas no
The CAS Registry Mumber 52328-48-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,2 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 52328-48:
(7*5)+(6*2)+(5*3)+(4*2)+(3*8)+(2*4)+(1*8)=110
110 % 10 = 0
So 52328-48-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O3/c1-12(2,3)8-5-6-9(11(13)14)10(7-8)15-4/h5-7H,1-4H3,(H,13,14)
52328-48-0Relevant articles and documents
SUBSTITUTED BIPIPERIDINYL DERIVATIVES
-
Paragraph 0595; 0596; 0597; 0598, (2016/11/17)
The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.
